Molecular Surveillance of Artemisinin-Based Combination Therapies Resistance in Plasmodium falciparum Parasites from Bioko Island, Equatorial Guinea

Domain:

healthcare

Creator:

YaQXueJiaJia

Publisher:

Ame

Host:

Malaria, one of the tropical parasitic diseases with a high transmission rate in Bioko Island, Equatorial Guinea, especially caused by P. falciparum is highly prevalent in this region and is commonly treated locally with ACTs. The declining antimalarial susceptibility of artemisinin-based drugs suggested that resistance to artemisinin and its derivatives is developing in P. falciparum .

Visit

doi.org

Licenses

https://creativecommons.org/licenses/by/4.0/https://journals.asm.org/non-commercial-tdm-license

Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo

Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018

Abstract Background Due to the threat of emerging anti-malarial

Genetic polymorphism of Plasmodium falciparum circumsporozoite protein (PfCSP) on Bioko Island, Equatorial Guinea and global comparative analysis

Abstract Background Plasmodium falciparum circumsporozoite protein ( PfCSP ) is a pote

REDUCTION IN INFECTION WITH PLASMODIUM FALCIPARUM ONE YEAR AFTER THE INTRODUCTION OF MALARIA CONTROL INTERVENTIONS ON BIOKO ISLAND, EQUATORIAL GUINEA

The Bioko Island Malaria Control Project was initiated in 2003 to substantially reduce malaria on th

A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria

Artemisinins are the cornerstone of anti-malarial drugs1. Emergence and spread of resistance to them

Configuration of volcanic rifts on Bioko Island (Equatorial Guinea)

The Cameroon Volcanic Line (CVL) hosts volcanoes within a complex tec